MANGALAM2023-10-012023-12-31 MANGALAM2023-10-012023-12-31 MANGALAM2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member MANGALAM2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member MANGALAM2023-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532637 MANGALAM NOTLISTED Mangalam Drugs And Organics Limited Equity 2023-04-01 2024-03-31 2024-02-13 2024-02-06 INR Lakhs Third quarter 16:30:00 19:30:00 2024-02-13 2024-02-13 Not applicable Single segment Manufacturing of Bulk Drugs 2023-10-01 2023-12-31 Unaudited Consolidated 973359000.00 19000.00 973378000.00 466480000.00 19890000.00 206281000.00 89712000.00 33095000.00 36285000.00 121217000.00 972960000.00 418000.00 0.00 418000.00 -1061000.00 -3500000.00 -4561000.00 0.00 4979000.00 0.00 0.00 0.00 0.00 4979000.00 312000.00 5291000.00 0.00 0.00 0.00 0.00 158282000.00 10 0.31 0.31 0.00 0.00 0.31 0.31 0.00 0.00 0.00 1.The above financial results have been prepared in accordance with Indian Accounting Standard (Ind AS) notified under section 133 of the companies Act, 2013, read together with Companies (Indian Accounting Standard) Rules, 2015 and relevant amendment rules thereafter. 2.The above Unaudited Consolidated financial results of the Company for the Quarter and Nine months ended have been reviewed by the Audit Committee and thereafter, approved and taken on record by the Board of Directors of Mangalam Drugs and Organics Limited (Company) at their meeting held on February 13, 2024. 3.The Company's business activity falls within a single reportable Business Segment Viz. “Manufacturing of Bulk Drugs”. 4.The figures for the quarter ended 31st December, 2023 are the balancing figures between the figures in respect of the nine months ended 31st December, 2023 and the unaudited published figures for half year ended on 30th September 2023 5.Consolidated results includes results of Mangalam Laboratories Private Limited, (MLPL) a wholly-owned subsidiary for the purpose of Consolidated results. 6.As on September 30, 2023 the Company has acquired 3010 Equity shares of MLPL of Rs. 100 each. MLPL became a wholly owned subsidiary of the Company .The wholly owned subsidiary is not a material subsidiary of the Company on acquisition. 7.Since the Company, has acquired Control on September 30, 2023, the consolidation of accounts are applicable from September 30, 2023. Hence figures for the quarter ended September 30,2023, December 31,2022, nine months ended December 31,2022 and year ended March 31, 2023 are not applicable to the Company Single segment 2023-04-01 2023-12-31 Unaudited Consolidated 2663595000.00 504000.00 2664099000.00 1732054000.00 26333000.00 100161000.00 279648000.00 99662000.00 107865000.00 468394000.00 2814117000.00 -150018000.00 0.00 -150018000.00 0.00 -24000000.00 -24000000.00 0.00 -126018000.00 0.00 0.00 0.00 0.00 -126018000.00 936000.00 -125082000.00 0.00 0.00 0.00 0.00 158282000.00 10 -7.96 -7.96 0.00 0.00 -7.96 -7.96 0.00 0.00 0.00 Other Expenses 121217000.00 Other Expenses 468394000.00